Monte Rosa Therapeutics PAO Edmund Dunn to retire; Matthew Bowen appointed successor

Monte Rosa Therapeutics, Inc.

Edmund Dunn, SVP, Corporate Controller and PAO, to retire effective April 3, 2026; no severance or disagreement.
Matthew Bowen, age 37, promoted from Director, Finance to Corporate Controller and PAO effective April 3, 2026.
Bowen joined Monte Rosa in June 2021 post-IPO; previously 7 years at Ernst & Young in audit.
Bowen holds BS and MS in Accounting from Bryant University and is a licensed CPA in Massachusetts.
No family relationships or related party transactions with Bowen; no arrangements for promotion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.